SMS Lifesciences India Share Price

SMS Lifesciences

CMP as on 23-May-22 13:36

₹ 621.50
-9.25 -1.47%

Open

₹ 635.00

Turnover (lac)

₹ 1

Prev. Close

₹ 630.75

Day's Vol (shares)

₹ 202

Day's Range (₹)

₹ 618.20
₹ 635.00

CMP as on23-May-22 13:26

₹ 624.10
-5.35 -0.85%

Open

₹ 632.30

Turnover (lac)

Prev. Close

₹ 629.45

Day's Vol (shares)

₹ 4

Day's Range

₹ 624.10
₹ 632.30

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 05-Feb-2022 - -
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve Enclosed copy of Board Meeting intimation. Enclosed outcome of Board meeting. (financial results) Re-appolnfmenf of Mr. P Sarafh Kumar [DIN: 01456746] as Independenf Dlrecfor of the Compa ny [whose c urrenl tenure will come to an end on May 24, 2022] for the second tenure of 5 (five) years w.e.1. May 25, 2022. The said appointment shall be subject to the a pproval of the shareholders by way of a Special Resolution in the ensuing General Meeting. (As Per BSE Announcement dated on 11.02.2022) Enclosed copies of newspaper advertisement. (As Per BSE Announcement Dated 14.02.2022)
Board Meeting - 24-Nov-2021 - -
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/11/2021 ,inter alia, to consider and approve i) Disinvestment of equity shares of Mahi Drugs Private Limited, a wholly-owned subsidiary of the Company and such other connected matters thereof. ii) Any other items as may be decided by the Board of Directors. Disclosure pursuant to Regulafion 30 of the SEBI (listing Obllgafions and Disclosure Requlremenfs) Regulations, 2015. (As per BSE Announcement Dated on 30/11/2021)
Board Meeting - 08-Nov-2021 - -
Quarterly Results Enclosed copy of Outcome of Board Meeting (As Per BSE Announcement dated on 13.11.2021) Dr. (Mr.) Mannam Malakondaiah [DIN: 01431923] and Dr. (Mr.) Srinivas Samavedam [DIN: 02488555] are appointed as Independent Directors of the Company, with immediate effect, for a term of 5 (five) consecutive years, subject to the approval of Shareholders. (As Per BSE Announcement Dated on 14.11.2021)
Board Meeting - 27-Aug-2021 - -
Inter alia, to consider the following: i) approval of the Board Report for the year 2020-21, ii) fixing the date of 15th Annual General Meeting, iii) appointment of Director, iv) any other items as may be decided by the Board of Directors. Otcome of Board meeting held on September 2, 2021. (As per BSE Announcement Dated on 2/9/2021)
Board Meeting - 07-Aug-2021 - -
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve i) Unaudited financial results (Standalone a nd Consolidated) of the Company for the first quarter ended June 30 2021 . ii) The request received from Promoter/Promoter Group regarding reclassification to Public category pursuant to Regulation 31 (A) of SEBI (Listing obligations and Disclosure Requirements) Regulations 2015. iii) any other items as may be decided by the Board of Directors. we would like to inform you that the Board of Directors of the Company at their Meeting held on August 13, 2021, have inter-alia considered and approved the un-audited [Standalone and Consolidated] financial results for the quarter ended June 30, 2021, as recommended by the Audit Committee. (As per BSE Announcement Dated on 13/8/2021) We would like to inform the Stock Exchange that the Board of Directors of the Company in its meeting held yesterday (i.e. August 13, 2021), consider the request received from the Promoter and Promoter Group to reclassify their shareholdings in the Company from Promoter and Promoter Group category to Public category. [Extract of Minutes is enclosed herewith]. Enclosed herewith copies of the newspaper advertisements published in Business Standard & AndhraPrabha on August 14, 2021, regarding financial results for quarter ended June 30, 2021. (As Per BSE Announcement Dated 14.08.2021)
Board Meeting - 01-Jun-2021 - -
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/06/2021 ,inter alia, to consider and approve We would like to inform you that the meeting of the Board of Directors of the Company has been scheduled to be held on Monday, June 7, 2021, inter alia, to consider and approve the audited financial results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021. SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/06/2021 ,inter alia, to consider and approve Update on board meeting, we would like to inform that in the Board Meeting scheduled to be held on Monday, June 7, 2021, Board shall also discuss to consider inter-alia the recommendation of declaration of dividend, if any for the financial year 2020-21, along with other agenda item(s) (AS Per BSE Announcement Dated on 02.06.2021) The Board Meeting to be held on 07/06/2021 has been revised to 18/06/2021 The Board Meeting to be held on 07/06/2021 has been revised to 18/06/2021 (AS Per BSE Announcement Dated on 06.06.2021) SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2021, inter alia, have recommended a dividend of Rs. 1.50/- (15%) per equity share of Rs. 10 face value for the Financial year 2020-21. The dividend will be paid on or after five days from the date of approval by the shareholders at the 15th AnnualGeneral Meeting (AGM). We would like to inform you that the Board of Directors of the Company at their Meeting held today i.e. June 18, 2021, have inter-alia considered and approved the Audited [Standalone & Consolidated] Financial results for the quarter and year ended 31st March, 2021 and ecommended a dividend of Rs. 1.50/- (15%) per equity share of Rs.10 face value for the financial year 2020-21. (As Per BSE Announcement Dated on 6/18/2021 6:18:25 PM) We hereby inform that Mr. Ramesh Babu Potluri has conveyed his decision to resign from the position of Non-Executive Director of the Company with immediate effect. The Board of Directors approved the same with effect from the close of business hours on June 18, 2021. Board of Directors of the Company, at its Meeting held yesterday i.e, June 18, 2021 has approved the REAPPOINTMENT of following Auditors: 1. Statutory Auditors for the Second Term of 5 (five) years 2. Secretarial Auditors for the year 2021-22 3. Cost Auditors for the year 2021 -22 (As Per BSE Announcement Dated 19.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity